Research suggests HPV vaccines prevent cancer in men as well as women

New research highlights the significant impact of the HPV vaccine in preventing cancer in both men and women, although fewer boys than girls are getting vaccinated in the United States. Originally developed to prevent cervical cancer in women, the HPV vaccine is now showing promising results in reducing HPV-related cancers in men.

The study compared 3.4 million vaccinated and unvaccinated individuals and found that vaccinated men had a lower risk of developing cancers of the anus, penis, mouth, and throat. Specifically, there were 57 HPV-related cancers among unvaccinated men compared to 26 in vaccinated men.